have a secondary pattern of antibody response, with rapid production of IgG to high titers. Thus, the IgM:IgG ratio can be used to distinguish primary from secondary flavivirus infection [10, 11] . Infection with JEV is followed by lifelong immunity to the virus. Patients who fail to produce antibody are more likely to have virus isolated from their CSF and are more likely to die [9] .
The early innate immune response and the cellular immune response during JE have been less well characterized, although interferon (IFN)-a, tumor necrosis factor (TNF)-a, and the chemokine interleukin (IL)-8 have each been associated with a bad outcome in small studies [12] [13] [14] . In animal models of viral central nervous system (CNS) infection, Th2 responses, characterized by the production of IL-4 (which supports the differentiation of B cells for production of antibody), appear to be protective [15, 16] . In contrast, Th1 responses, characterized by the production of IFN-g, favor the activation of macrophages (which produce proinflammatory cytokines and reactive oxygen and nitrogen intermediates) and cytotoxic T cells, which may sometimes be detrimental [17, 18] . Recent data from animal models of West Nile virus infection [19] and of other flavivirus infection [20] suggest that there may be immunopathology, which, if confirmed in humans, could point the way toward future therapeutic targets. To examine whether unregulated inflammatory responses play a role in the pathogenesis of JE in humans, we prospectively studied a series of Vietnamese patients. In addition to measuring the levels of the cytokines IFN-a, IFN-g, TNF-a, IL-4, and IL-6, we measured the levels of the chemokines IL-8 and RANTES and the reactive nitrogen intermediate nitric oxide (NO).
PATIENTS, MATERIALS, AND METHODS

Patients and setting.
Between December 1994 and November 1998, children and adults with JE were investigated during studies of patients with a suspected CNS infection who were admitted to the pediatric and adult intensive care units of the Hospital for Tropical Diseases (Ho Chi Minh City), an infectious diseases referral hospital for southern Vietnam, where JEV is endemic [21] [22] [23] [24] . Study protocols were approved by the Scientific and Ethical Committee of the Hospital for Tropical Diseases, and consent was obtained from each patient's accompanying relative. A CNS infection was suspected in patients with fever or a history of fever and at least 1 of the following: reduced level of consciousness (either a Glasgow coma score р14 or, for children !6 years old, a Blantyre coma score р4 [25] ), severe headache, neck stiffness, tense fontanelle, focal neurological signs, or seizures. Children between 6 months and 5 years old who had a single convulsion lasting !15 min and who recovered consciousness within 60 min were considered to have had a simple febrile convulsion and were not studied.
For study patients, a detailed history was taken, and a clinical examination, including a full neurological examination, was performed by a member of the study team. On admission to the hospital, a lumbar puncture (LP) was performed in the left lateral position, and, if the patient was calm, opening pressures were measured with a spinal fluid manometer. LP was delayed for convulsing patients or for those with clinical signs of raised intracranial pressure. CSF samples were collected for cell counts and for differential, protein, glucose, lactate, Gram stain, bacterial culture, viral culture, and cytokine assays, as described below. Serum samples were collected for hematocrit, examination for malarial parasites, platelet count, differential white cell count, blood cultures, glucose assay, lactate assay, biochemical screen, viral culture, serological testing, and cytokine analysis. Patients were examined daily-or more frequently, as warranted-until death, stabilization, or discharge from the hospital.
Diagnosis of JE. Levels of IgM to JEV were evaluated in acute and convalescent serum and CSF samples by use of a rapid IgM dot-enzyme immunoassay that distinguishes between antibodies to JEV and dengue virus [24] . Levels of IgM and IgG were subsequently measured by use of a double sandwich capture ELISA [10, 26, 27] . For serum and CSF samples, у40 U of IgM to JEV (with IgM to JEV greater than IgM to dengue virus) was considered to be evidence of an acute JEV infection; for paired samples, an increase from !15 U to 130 U was considered to be evidence of an acute JEV infection [10, 26, 27] . These assays, which have high sensitivity and specificity after the first few days of illness, have become the accepted standard for diagnosis of JE [11, 28] . An IgM:IgG ratio у1.8:1 was considered to be evidence of a primary flavivirus infection, whereas a ratio !1.8:1 was considered to be evidence of a secondary flavivirus infection (i.e., the patient had been previously infected with a different flavivirus) [10] . These criteria were derived for distinguishing between primary and secondary dengue virus infection and have not been formally assessed for JEV infection [10, 21] . Therefore, we also applied more-recently devised criteria for distinguishing between primary and secondary infection, in which a secondary infection is diagnosed if the level of IgG to dengue virus in serum is 135 U, and a primary infection is diagnosed if the level of IgG to dengue virus is р35 U, in у2 samples, with the last sample collected between day 7 and day 14 after the onset of illness [7] . Although these newer criteria have been validated against hemagglutination inhibition assays, they have the disadvantage of being unable to diagnose a primary infection in patients who die during the first week of illness. For isolation of JEV, autopsy material and acute serum and CSF samples were inoculated into Aedes albopictus C6/36 cells, rhesus monkey kidney (LLC-MK2) cells, and Vero cells [6, 23] .
Determination of cytokine, chemokine, and NO levels. Se-rum samples (2 mL) were collected in EDTA tubes and were centrifuged, and the plasma was separated. CSF and plasma samples were stored at Ϫ70ЊC until they were transported to the United Kingdom on dry ice for analysis. Multiple logistic regression was used to assess the relationships between multiple variables and outcome (SPSS software; version 10). To examine changes in cytokine levels during the first few days of disease, median cytokine levels on days 2-3 of illness were compared with those on days 4-5 of illness.
RESULTS
Patients.
One-hundred eighteen patients infected with JEV were studied, comprising 112 children (median [total range] age, 7 [1.6-14.9] years) and 6 adults (median [total range] age, 16 years). At least 1 plasma sample was available for all of the patients. For 59 patients (54 of them children) it was possible to measure cytokine levels in CSF as well as in plasma, and for 25 patients it was possible to obtain a second plasma level ∼48 h after the first. Thirteen (11%) patients died (median [total range] hours after admission, 74 h). Twentysix (22%) had severe, 36 (31%) had moderate, and 22 (19%) had mild sequelae; 21 (18%) appeared to have made a full recovery when discharged from the hospital. A comparison of the clinical features of the nonsurvivors and survivors is shown in table 1. The nonsurvivors were significantly more likely to be comatose, to have rigidity spasms, to have abnormal oculocephalic reflexes, and to have elevated CSF opening pressures. The 59 patients for whom CSF samples were available were representative of all of the patients with regard to age (median [interquartile range {IQR}, total range] for the 59 patients, 7 [5-11, 1.6-75] years), length of illness (4 [3-6, 2-4] days), the number in a coma on admission (38 [64%] ), and the number with fatal outcome (8 [14%] ). JEV was isolated from the CSF of 1 patient with a relatively low IgM level and no detectable IgG; this patient died on the seventh day after admission to the hospital.
Distribution of cytokine levels. For most of the biomolecules, the distribution of levels in CSF and plasma was highly skewed to the left, because many samples had undetectable levels. The percentages of patients with undetectable levels in CSF were as follows: TNF-a, 23%; IFN-a, 63%; IFN-g, 44%; IL-4, 27%; IL-6, 13%; and RANTES, 14%. The percentages of patients with undetectable levels in plasma were as follows: TNF-a, 66%; IFN-a, 67%; IFN-g, 63%; IL-4, 37%; IL-6, 32%; and IL-8, 7%. Therefore, these data sets could not be transformed toward normality and were analyzed by use of nonparametric tests. However, levels of NO in CSF and plasma were detectable for all of the patients and were log transformable toward normality. In addition, levels of RANTES in plasma were normally distributed.
Univariate analysis of cytokine levels and outcome. Levels of IL-6, IL-8, and IFN-a were significantly higher in the CSF of the nonsurvivors than in that of the survivors, and TNF-a showed a trend toward higher levels in the nonsurvivors (table  2) . In contrast, levels of IgM and IgG in CSF were higher in the survivors than in the nonsurvivors. Only in plasma were levels of RANTES significantly higher in the nonsurvivors than in the survivors, whereas levels of IgM in plasma were higher in the survivors than in the nonsurvivors. Levels of NO in both CSF and plasma were similar for the nonsurvivors and survivors. A level of IL-6 in CSF 1250 pg/mL predicted a fatal outcome (sensitivity, 88% [95% confidence interval {CI}, 80%-96%]; specificity, 56% [95% CI, 43%-69%]) ( ). How-P p .026 ever, the best predictor of fatal outcome was a level of IgG in CSF !15 U (sensitivity, 92% [95% CI, 86%-98%]; specificity, 57% [95% CI, 46%-68%]) ( ). P p .006 Primary versus secondary flavivirus infection. Thirteen (14%) of the 91 patients with a primary flavivirus infection (as defined by the IgM:IgG ratio) died, compared with none of the 27 patients with a secondary infection ( ). For all P p .038 of the patients, at least 1 plasma sample was available for analysis, and, for 59, a CSF sample was also available. A comparison of the cytokine levels in patients with a primary versus a secondary infection showed that, for most cytokines, the levels were similar. However, none of the 10 patients with a secondary flavivirus infection had detectable levels of IFN-a in CSF, com- pared with 18 (46%) of the 39 patients with a primary infection ( ). Subgroup analysis examining only the patients with P p .007 a primary infection showed significantly higher levels of IL-6 in CSF (
) and of RANTES in plasma ( ) (data P p .007 P p .04 not shown), compared with those in the patients with a secondary infection. Within this subgroup, median levels of IgM and IgG in CSF were lower in the nonsurvivors than in the survivors ( and , respectively). For the patients P p .004 P p .03 with a primary infection, a level of IL-6 in CSF 1250 pg/mL predicted a fatal outcome, with a sensitivity of 88% (95% CI, 79%-97%) and a specificity of 53% (95% CI, 39%-67%) ( ), and a level of IgG in CSF !15 U also predicted a P p .055 fatal outcome, with a sensitivity of 92% (95% CI, 84%-97%) and a specificity of 57% (95% CI, 43%-71%) ( ). P p .019 All of the 27 patients classified as having a secondary flavivirus infection by the IgM:IgG ratio were also classified as having a secondary infection by the more-recent criteria (IgG 135 U). Of the 91 patients classified as having a primary infection by the IgM:IgG ratio, 9 could not be classified by the more-recent criteria, and 6 were classified as having a secondary infection. Nonetheless, comparison of levels of cytokines in the patients classified as having a primary or a secondary infection using the more-recent criteria gave similar results. One (7.7%) of the 13 patients with a secondary flavivirus infection had a detectable level of IFN-a in CSF, compared with 11 (39.3%) of the 28 patients with a primary infection ( ). P p .06 Relationship between biomolecules. Because failure to produce antibody is strongly associated with a fatal outcome during JE, we examined the relationship between cytokine and immunoglobulin levels. Levels of IL-8 and IL-6 in CSF were significantly inversely related to levels of IgM in CSF (r p 0.424 and , respectively; and , respecr p 0.346 P p .005 P p .02 tively), but none of the other biomolecules was correlated with levels of IgM or IgG in CSF. Repeating this analysis for only the patients with a primary infection (as defined by the IgM: IgG ratio) showed that levels of IL-8 and IL-6 in CSF both remained inversely correlated to levels of IgM in CSF (r p and , respectively; and , re-0.445 r p 0.495 P p .006 P p .003 spectively). For the patients with a secondary flavivirus infection, there was no correlation. Levels of IgM in plasma were significantly correlated with those of IL-8 ( ; P p .02), r p 0.234 IFN-a ( ; ), and TNF-a ( ;P p .002). r p 0.245 P p .018 r p 0.33 For the patients with a primary infection but not for the patients with a secondary infection, levels of IgM in plasma remained significantly correlated with those of IFN-a ( ; r p 0.255 P p ) but not with those of IL-8 or TNF-a. As a measure of .031 the balance between proinflammatory cytokines and humoral immunity and its relationship to survival, we determined, for ). These findings remained P p .008 significant when only the patients with a primary infection were examined. We looked at the ratio of the levels of IL-6 and IL-4 in CSF as a measure of the balance of pro-and anti-inflammatory cytokines. The median (IQR, total range) CSF IL-6:IL-4 ratio was 18.6 (8.8-39.7, 2.6-75.0) in the nonsurvivors and was 1.8 (0.2-8.6, 0-29.5) in the survivors ( ). For the P p .005 patients with a primary infection, the median (IQR, total range) CSF IL-6:IL-4 ratio was 18.6 (8.8-39.7, 2.6-75.0) in the nonsurvivors and was 1.8 (0.5-7.9, 0-18.0) in the survivors (P p .004). There were positive correlations between most of the levels of pro-and anti-inflammatory cytokines in CSF or plasma (data not shown). We also looked for a correlation between the level of each biomolecule measured in CSF and plasma but found none, suggesting that levels in CSF represent local production within the CNS, rather than production in the periphery. To determine whether 1 cytokine level in CSF was associated with death independent of the other cytokine levels and of clinical features, variables associated with death in univariate analyses were included as independent variables in a stepwise logistic regression, with death as the dependent variable. The level of IL-6 in CSF remained an independent risk factor and was significantly associated with fatal outcome (odds ratio [95% CI], 1.002 [1.001-1.004]) (P p .008) in both forward-selection and backward-elimination methods.
Relationship with clinical features. Because raised intracranial pressure and cerebral edema are thought to be important in the pathophysiology of JE, we examined the relationship between proinflammatory cytokines and clinical features of brain stem dysfunction. The patients with a history of rigidity spasm (a clinical marker of brain stem dysfunction) had higher levels of NO in CSF than did those without a history of rigidity spasm (median [IQR, total range], 60.5 [36.9- the CNS, the relationship between biomolecule levels and white cell counts in CSF was examined by use of Spearman's rank correlation. This analysis showed an association between white cell count and levels of RANTES in CSF ( ; P p .0002) r p 0.544 (figure 1), which remained when only the patients with primary infection were examined ( ; ). Analysis when r p 0.476 P p .003 different white cell types within CSF was allowed for showed that the association between CSF lymphocyte count and levels of RANTES was stronger than that between CSF neutrophil count and levels of RANTES (data not shown). There was no significant association between levels of other biomolecules and CSF cell counts.
Variation by day of illness. In figure 2 , the median levels of IL-6, IL-8, and IFN-a in CSF are compared for the nonsurvivors and survivors according to the day of illness. Comparison of the median levels on days 2-3 of illness with those on days 4-5 of illness showed that levels of IL-6 in CSF were initially similar in both patient groups but tended to increase during the first few days of illness in the nonsurvivors, compared with the levels in the survivors ( ). For levels of P p .042 IFN-a in CSF, there was a trend toward higher initial levels in the nonsurvivors ( ), which subsequently decreased. P p .089
DISCUSSION
There is no established antiviral treatment for JEV, West Nile virus, or indeed any other member of the Flavivirus genus. However, in a range of animal models of viral CNS infection, including for West Nile virus [19] and other flaviviruses [20] , there is evidence that some of the damage may be mediated by the immune response itself, which could have implications for possible future therapeutic targets. The present study, the largest investigation to date of cytokines and chemokines (both in terms of number of patients and number of parameters) for any acute viral encephalitis, has provided clinical data consistent with the hypothesis that an unregulated proinflammatory response could be detrimental in flavivirus encephalitis. In previous studies examining a single biomolecule during JE, levels of TNF-a, IL-8, and IFN-a have been associated with a poor outcome [12] [13] [14] . The present study has confirmed the importance of these molecules and has also shown the importance during JE of IL-6 (which increases blood-brain barrier permeability) and RANTES (which attracts lymphocytes). Although examining a wide range of markers of the innate, humoral, and cellular immune responses necessarily required multiple comparisons, it had the advantage of allowing us to examine the interactions between different components of the immune system. We decided not to formally adjust for multiple testing, because of the increased risk for type II errors associated with this type of adjustment (such that truly important differences may have been deemed nonsignificant) [29] . However, if, to allow for multiple comparisons, we take rather than P ! .01 to be significant, most of our observations on antibody P ! .05 production and the relationships with pro-and anti-inflammatory cytokines remain significant. It was intended that the molecules chosen would give us information on various aspects of the immune response, although, because of the multifunctionality of many biomolecules and the widespread interactions between them, our interpretation is, inevitably, overly simplistic. Other possible confounding variables include differences in the timing of when samples were obtained and differences in the availability and processing of the samples. Despite this, certain patterns are evident. First, the innate immune response-as indicated by the production of IFN-is important during JE. IFNa was detected in the CSF of 37% of our patients, with a trend toward higher levels in the nonsurvivors, particularly during the first few days of illness (table 2 and figure 2) . Few of the patients had elevated levels of IFN-a in plasma, perhaps suggesting that, by the time the patients had presented to the hospital, the levels had already decreased. IFN-a is a glycoprotein cytokine that has antiviral effects against JEV in vitro and in animal models [30] and that is thought to be protective; as such, it was considered to be a possible treatment in human disease. However, a recently completed double-blind placebocontrolled trial of recombinant IFN-a2a in Vietnamese children with JE showed that it did not improve outcome [22] . It is possible that this result occurred because the disease was already well established by the time the patients had presented to the hospital. The significance of the trend observed in our study toward higher levels of IFN-a in CSF during more-severe disease is not certain, but it may reflect higher viral load.
If the immune response is unable to control JEV replication in the periphery, a brief viremia is thought to occur, followed by viral spread across the blood-brain barrier into the CNS [31] . A series of studies has shown that failure to produce antibody is associated with an increased risk of death [7, 9, 32] ; in one study, such patients were more likely to have virus isolated from their CSF [9] . In contrast, patients previously infected with a different flavivirus (in our setting, most often dengue virus, presumably) rapidly produce antibodies to epitopes that are common to dengue virus and JEV and are less likely to die [7, 8] . This anamnestic response to common flavivirus antigens is thought to explain the reduced rates of clinical attack and case fatality for JEV in dengue-immune subjects [9, [33] [34] [35] . However, prior flavivirus exposure is unlikely to be the only explanation for the differing antibody responses in the nonsurvivors and survivors in the present study, because, even among the patients with a primary infection (i.e., excluding the patients with prior flavivirus exposure), antibody responses (as determined by levels of IgM and IgG in CSF and of IgM in plasma) varied with outcome.
The immune response to viral infection of the CNS differs from that in the periphery, because of the potentially damaging consequences of cellular cytotoxicity, altered vascular permeability, and the influx of inflammatory cells to the brain [18, 36] . In the present study, levels of proinflammatory cytokines and chemokines were elevated in the CSF, plasma, or both of many of the patients, and higher levels of some of them (IL-6, IL-8, and TNF-a in CSF and RANTES in plasma) were found in the nonsurvivors, compared with those in the survivors. Because the nonsurvivors tended to present earlier, some of the differences between the 2 groups may be a reflection of dif- ferences between when the samples were obtained. However, that levels of IL-6 and IL-8 in CSF tend to increase over time argues against the theory that the earlier presentation of the nonsurvivors explains these higher levels. Moreover, a comparison between the time course in the nonsurvivors and that in the survivors showed that IL-6 levels were initially similar but that production then increased significantly for the nonsurvivors (figure 2). Several studies have shown that cytokines are produced by cells intrinsic to the CNS (especially microglial cells and perivascular macrophages) as part of the innate immune response to viral infection before the infiltration of inflammatory cells from the periphery [36] . The levels measured in the present study may, therefore, reflect this innate response, not an adaptive immune response. However, histological studies of patients who died of JE and of West Nile encephalitis have confirmed that perivascular cuffing often occurs with an acute inflammatory infiltrate of CD4 + and CD8 + lymphocytes [37] [38] [39] , suggesting that, later in the disease process, adaptive immune responses are likely important. In the present study, we found, interestingly, that levels of RANTES, a chemokine that attracts lymphocytes and can cause nonspecific activation, in CSF were correlated with lymphocyte counts in CSF, whereas elevated levels of RANTES in plasma were associated with a fatal outcome. This result contrasts with findings for meningococcal disease, during which RANTES appears to be protective [40] . In the present study, the patients with clinical signs of brain swelling had significantly higher levels of NO, a reactive nitrogen intermediate produced by activated macrophages as part of the respiratory burst. However, a randomized placebo-controlled trial of dexamethasone for the control of cerebral swelling in 55 Thai children with JE failed to show any benefit [41] . The associations between immune markers and fatal outcome observed in the present study do not necessarily imply causality. In a previous study of JE, fatality was related to isolation of the virus from CSF [9] , suggesting that the vigorous immune response we observed may simply be a response to high virus replication. In experimentally infected mice, cytokine, as part of the innate immune response, is produced in the CNS in proportion to the titer of the infecting virus [17] . Clearly, this important question needs to be addressed for JE. Interestingly, in some patients who died of JE, immunohistochemical studies reveal viral antigen in neurons but no associated inflammation [38] , suggesting that, in these patients, virusinduced neuronal dysfunction due to apoptosis or another mechanism may be important. In summary, the present study has shown that there are correlations between levels of proinflammatory cytokines and chemokines and fatal outcome during JE, but whether these are simply a correlate of severe disease or actually contribute to pathogenesis remains to be determined. A better understanding of the role played by viral and immunological factors during JE may direct us toward new treatments.
